v3.26.1
INVESTMENT IN EQUITY INSTRUMENTS
 12 Months Ended
Dec. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENT IN EQUITY INSTRUMENTS

NOTE 12 – INVESTMENT IN EQUITY INSTRUMENTS

 

During the year ended December 31, 2025, the Company entered into investment-related transactions primarily in connection with its strategic licensing and development arrangements. These investments primarily consist of equity securities received as compensation under contractual agreements. Specifically, in connection with a multi-year licensing and development agreement (the “Sagtec transaction”), the Company received consideration that included:

 

·Equity securities of a publicly traded entity, and
·Rights to future revenue participation tied to commercialization activities.
·The equity consideration received was recorded as an investment at its fair value on the date of receipt, in accordance with U.S. GAAP.

 

The investments are primarily classified as equity securities and are accounted for under ASC 321, Investments – Equity Securities. Investments with readily determinable fair values are measured at fair value, with changes recognized in earnings.

 

As of December 31, 2025, the Company reported total investments of $10,460,540, representing a significant increase from the prior year, driven primarily by the recognition of equity received under the Sagtec transaction.

 

During the year ended December 31, 2025, the Company recognized investment income of $65,540, which is included in other income (expense) in the statement of operations.